Market News AIOpen the app

GeneDx Holdings shared its Q3 2026 results, showing $123.1 million in sales and $8.6 million in profit.

ResultsRead the original at Benzinga
Good for WGS

GeneDx raised its gross-margin and profit forecasts and kept its full-year sales forecast unchanged. New payment checks temporarily lower expected test volume, but stronger profit forecasts support a favorable read.

WGS · GeneDx Holdings

AI read · Good for WGS

The AI's read

The higher payment rate and better profit forecasts mean more of each testing dollar may remain after lab costs. New paperwork checks require records before testing and are lowering expected test volume for now, even though the company reports strong demand. Keeping the full-year sales forecast unchanged limits the concern, while raised profit forecasts support a favorable read.

Get alerts for WGS

Follow GeneDx Holdings (WGS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for WGS
Free on the App Store and Google Play, or on the web.